New drug reverses effects of sleep deprivation on brainAugust 23, 2005WINSTON-SALEM, N.C. - Research in monkeys suggests that a new drug can temporarily improve performance and reverse the effects of sleep deprivation on the brain, which would be a breakthrough in helping shift workers, health professionals, military personnel and others who must function at top performance in spite of sleep deficits. "In addition to improving performance under normal conditions, the drug restored performance that was impaired after sleep loss," said Samuel Deadwyler, Ph.D., senior researcher, from Wake Forest University School of Medicine. "Brain imaging revealed that one basis for the drug's effects was to reverse changes in brain patterns induced by sleep deprivation." The study's results are reported on-line today in the journal Public Library of Science- Biology. The drug, currently known as CX717, is designed to act on a type of receptor located throughout the brain that is involved in cell-to-cell communication. It has been tested in sleep-deprived humans with positive results, according to the developer, Cortex Pharmaceuticals.
The Wake Forest research was funded by the U.S. Department of Defense Advanced Research Projects Agency, as part of a larger effort to mitigate or eliminate the effect of sleep deprivation on military personnel, and by the National Institutes of Health. In addition to Deadwyler, the research team included Linda J. Porrino, Ph.D., James Daunais, Ph.D., Robert Hampson, Ph.D., from the Department of Physiology and Pharmacology at Wake Forest, and Gary Rogers from Cortex Pharmaceuticals. The researchers first tested normal, alert monkeys on a matching task similar to a video game. Each monkey was shown one clip art picture at one position on the screen, and after a delay of one to 30 seconds, picked the original out of a random display of two to six different images to get a juice reward. The monkeys were then given varying doses of the drug and re-tested. At the highest dose tested, the drug improved performance to near perfect for the easier trials and by about 15 percent overall. Next, the monkeys were tested after they were sleep-deprived for 30 to 36 hours, which Deadwyler estimates is equivalent to humans going 72 hours without sleep. When compared to when they were alert, the monkeys' overall performance was reduced under all test conditions, even on the easiest trials. But, when the monkeys were again sleep-deprived and re-tested after being given CX717, their performance was restored to normal levels. The researchers used positron emission tomography (PET) to gain images of brain activity while the animals were performing the matching task. These scans showed that the drug was able to reverse most of the changes in activity patterns that occurred with sleep deprivation - which may explain its success at increasing performance. The PET images showed that when the monkeys were performing the task while sleep-deprived, activity in the frontal cortex, an area of the brain associated with higher mental processing, decreased and activity in the temporal lobe, associated with memory for recent events, increased. The researchers suspect that this might be the brain's way of compensating for the effects of sleep deprivation. After the drug was administered, the brain patterns in these regions returned to normal. "The effect was to reverse the patterns of activation to the same as when the animal performed the task under normal conditions," Deadwyler said. "The drug didn't cause overall brain arousal, but increased the ability of certain affected areas to become active in a normal, non-sleep-deprived manner." The drug, known as an ampakine, is designed to target AMPA receptors that are located throughout the brain. These receptors are part of the cellular communication process that involves the neurotransmitter glutamate. The drug prolongs the action of glutamate, allowing more effective communication. Because the drug acts differently from caffeine and other stimulants, it does not seem to result in side effects such as hyperactivity, distorted thinking or extended wakefulness. "It's possible that ampakines could also be used to enhance other cognitive deficits, such as occur in Alzheimer's disease, after a stroke or other forms of dementia," Deadwyler said. Wake Forest University Baptist Medical Center | |||||||||||||||||||||
|
Related Sleep Deprivation Current Events and Sleep Deprivation News Articles High levels of prenatal smoking exposure affect sleep patterns in preterm neonates A study in the Dec. 1 issue of the journal Sleep is the first to show that high levels of prenatal smoking exposure strongly modify sleep patterns in preterm neonates, which places infants at a higher risk for developmental difficulties that could persist throughout early and middle childhood. Association found between severe obstructive sleep apnea A study in the October 15 issue of the Journal of Clinical Sleep Medicine shows that unrelated to obesity, people with severe SDBs consume a more unhealthy diet, which may be a factor contributing to greater cardiovascular morbidity and mortality. These findings were most evident among women. Loss of sleep, even for a single night, increases inflammation in the body Loss of sleep, even for a few short hours during the night, can prompt one's immune system to turn against healthy tissue and organs. Mom's mood, baby's sleep: what's the connection? If there's one thing that everyone knows about newborn babies, it's that they don't sleep through the night, and neither do their parents. Exploring the function of sleep Is sleep essential? Ask that question to a sleep-deprived new parent or a student who has just pulled an "all-nighter," and the answer will be a grouchy, "Of course!" Kids with pets grow up to be snorers A predisposition to adult snoring can be established very early in life. Research published today in BioMed Central's open access journal Respiratory Research describes possible childhood risk factors, including exposure to animals, early respiratory or ear infections and growing up in a large family. 1 sleepless night increases dopamine in the human brain Just one night without sleep can increase the amount of the chemical dopamine in the human brain, according to new imaging research in the August 20 issue of The Journal of Neuroscience. Less REM sleep associated with being overweight among children and teens Children and teens who get less sleep, especially those who spend less time in rapid eye movement (REM) sleep, may be more likely to be overweight, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Searching for shut eye: Penn study identifies possible sleep gene While scientists and physicians know what happens if you don't get six to eight hours of shut-eye a night, investigators have long been puzzled about what controls the actual need for sleep. Researchers at the University of Pennsylvania School of Medicine might have an answer, at least in fruit flies. In a recent study of fruit flies, they identified a gene that controls sleep. Animal study suggests inadequate sleep may exacerbate cellular aging in the elderly Researchers at the University of Pennsylvania School of Medicine have shown that the unfolded protein response, which is a reaction to stress induced by sleep deprivation, is impaired in the brains of old mice. More Sleep Deprivation Current Events and Sleep Deprivation News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||